Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

Summary

The goal of this study is to understand if the implementation of a remote symptom monitoring and management program improves outcomes. The program will provide patients the opportunity to complete electronic Patient Reported Outcomes (PROs) questionnaires from home between appointments and receive tailored advice from a study nurse. A second goal of this study is to examine the impact of electronic symptom monitoring on clinic efficiencies.

The main question it aims to answer is:

• What impact does implementing digitally enabled remote symptom monitoring and management (RESPONd) between ambulatory oncology visits have on patient outcomes and system efficiencies?

Participants will:

* Report their symptoms and concerns from home by completing the electronic symptom monitoring questionnaire.
* Discuss their symptoms and concerns with a study nurse.
* Provide feedback about their experience at important timepoints during the study.
* Participate as usual in ambulatory clinic appointments.

Conditions

• Cancer

Interventions

OTHER

Remote Symptom Monitoring and Management

A study nurse will digitally monitor symptom complexity and provide symptom management between clinic visits. This will increase the frequency of collection and use of electronic PROs to provide responsive symptom management. Electronic PROs are collected digitally, and a complexity algorithm is used to flag patients with high symptom complexity. This will allow the study nurse to proactively manage symptoms in a timelier way.

OTHER

Clinic Team Huddle

Support will be provided to clinic teams to implement a team huddle (team planning session) one week prior to clinics, to assess how additional electronic PROs data for patients participating in RESPONd impacts their ability to identify stable patients with low symptom complexity who could receive virtual care or Registered Nurse (RN) led clinic care.

Sponsors & Collaborators

• Alberta Health services

  collaborator OTHER

• Alberta Innovates Health Solutions

  collaborator OTHER

• University of Calgary

  lead OTHER

Principal Investigators

• Linda Watson, RN, PhD · Cancer Care Alberta, Alberta Health Services

• Marni Armstrong, PhD · Cancer Care Alberta, Alberta Health Services

Study Design

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-05-16

Primary Completion

2026-11-30

Completion

2027-03-31

Countries

• Canada

Study Locations